Prospects for a dengue virus vaccine

By S. Whitehead, J. Blaney, A. Durbin, B. Murphy. Nature Reviews Microbiology, 2007

659 citations recorded by the source corpus.

Subfields: Infectious Diseases, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/b50217fd285de95e74e9b760d7d9ef5d446c3600

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. J. Shang
2. Yushun Wan
3. Q. Geng
4. Rafi Ahmed
5. E. Harris
6. L. Du
7. Fang Li
8. J. Kyle

In Public Health, Environmental and Occupational Health

1. E. Harris
2. J. Kyle

Citations in the corpus

• From Vaccines to Memory and Back (2010, positive): “…such as HIV, Mycobacterium tuberculosis, Plasmodium falciparum, HCV, RSV and dengue virus (Hall, 2001; Hill, 2006; Houghton and Abrignani, 2005; Johnston and Fauci, 2007; Langhorne et al., 2008; McMichael et al., 2010; Skeiky and Sadoff, 2006; Walker and Burton, 2008; Whitehead et al., 2007).”
• The enemy who sealed the world: effects quarantine due to the COVID-19 on sleep quality, anxiety, and psychological distress in the Italian population (2020, neutral): “Our results differ from previously observed ADE of flaviviruses in which primary infections and secondary infections are caused by two different viral strains and in which ADE-mediating MAbs are only subneutralizing or nonneutralizing for secondary viral infections (3) (4) (5) (6) .”
• Dengue: a continuing global threat (2010, background): “The ideal dengue vaccine should be free of important reactogenicity, induce life-long protection against infection with any of the four DENV serotypes and be affordable 126,127 .”
• Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry (2019, result): “Our results differ from previously observed ADE of flaviviruses in which primary infections and secondary infections are caused by two different viral strains and in which ADE-mediating MAbs are only subneutralizing or nonneutralizing for secondary viral infections (3) (4) (5) (6) .”
• Global spread and persistence of dengue. (2008, background): “A great deal of work is currently directed to the development of tetravalent dengue vaccines and specific antivirals, which will hopefully provide additional tools for reducing the health impact of dengue in the near to mid-term future (66, 71, 154).”